Specific DNA identification of Pheretima in the Naoxintong capsule

Abstract Background Pheretima is a minister drug in Naoxintong capsule (NXTC), a well-known traditional Chinese medicine (TCM) formula for the treatment of cardiovascular and cerebrovascular diseases. Owing to the loss of morphological and microscopic characteristics and the lack of recognized chemi...

Full description

Bibliographic Details
Main Authors: Xiaoxiao Zhu, Hoi-Yan Wu, Pang-Chui Shaw, Wei Peng, Weiwei Su
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Chinese Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13020-019-0264-7
_version_ 1818534554128875520
author Xiaoxiao Zhu
Hoi-Yan Wu
Pang-Chui Shaw
Wei Peng
Weiwei Su
author_facet Xiaoxiao Zhu
Hoi-Yan Wu
Pang-Chui Shaw
Wei Peng
Weiwei Su
author_sort Xiaoxiao Zhu
collection DOAJ
description Abstract Background Pheretima is a minister drug in Naoxintong capsule (NXTC), a well-known traditional Chinese medicine (TCM) formula for the treatment of cardiovascular and cerebrovascular diseases. Owing to the loss of morphological and microscopic characteristics and the lack of recognized chemical marker, it is difficult to identify Pheretima in NXTC. This study aims to evaluate the feasibility of using DNA techniques to authenticate Pheretima, especially when it is processed into NXTC. Methods DNA was extracted from crude drugs of the genuine and adulterant species, as well as nine batches of NXTCs. Based on mitochondrial cytochrome c oxidase subunit I (COI) gene, specific primers were designed for two genera of genuine species, Metaphire and Amynthas, respectively. PCR amplification was performed with the designed primers on crude drugs of Pheretima and NXTCs. The purified PCR products were sequenced and the obtained sequences were identified to species level with top hit of similarity with BLAST against GenBank nucleotide database. Results Primers MF2R2 and AF3R1 could amplify specific DNA fragments with sizes around 230–250 bp, both in crude drugs and NXTC. With sequencing and the BLAST search, identities of the tested samples were found. Conclusion This study indicated that the molecular approach is effective for identifying Pheretima in NXTC. Therefore, DNA identification may contribute to the quality control and assurance of NXTC.
first_indexed 2024-12-11T18:13:09Z
format Article
id doaj.art-150ff08bc7d145b387b8a964f87c0656
institution Directory Open Access Journal
issn 1749-8546
language English
last_indexed 2024-12-11T18:13:09Z
publishDate 2019-09-01
publisher BMC
record_format Article
series Chinese Medicine
spelling doaj.art-150ff08bc7d145b387b8a964f87c06562022-12-22T00:55:30ZengBMCChinese Medicine1749-85462019-09-011411810.1186/s13020-019-0264-7Specific DNA identification of Pheretima in the Naoxintong capsuleXiaoxiao Zhu0Hoi-Yan Wu1Pang-Chui Shaw2Wei Peng3Weiwei Su4Guangdong Engineering and Technology Research Center for Quality and Efficacy Reevaluation of Post-Market Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-Sen UniversityLi Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong KongLi Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong KongGuangdong Engineering and Technology Research Center for Quality and Efficacy Reevaluation of Post-Market Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-Sen UniversityGuangdong Engineering and Technology Research Center for Quality and Efficacy Reevaluation of Post-Market Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-Sen UniversityAbstract Background Pheretima is a minister drug in Naoxintong capsule (NXTC), a well-known traditional Chinese medicine (TCM) formula for the treatment of cardiovascular and cerebrovascular diseases. Owing to the loss of morphological and microscopic characteristics and the lack of recognized chemical marker, it is difficult to identify Pheretima in NXTC. This study aims to evaluate the feasibility of using DNA techniques to authenticate Pheretima, especially when it is processed into NXTC. Methods DNA was extracted from crude drugs of the genuine and adulterant species, as well as nine batches of NXTCs. Based on mitochondrial cytochrome c oxidase subunit I (COI) gene, specific primers were designed for two genera of genuine species, Metaphire and Amynthas, respectively. PCR amplification was performed with the designed primers on crude drugs of Pheretima and NXTCs. The purified PCR products were sequenced and the obtained sequences were identified to species level with top hit of similarity with BLAST against GenBank nucleotide database. Results Primers MF2R2 and AF3R1 could amplify specific DNA fragments with sizes around 230–250 bp, both in crude drugs and NXTC. With sequencing and the BLAST search, identities of the tested samples were found. Conclusion This study indicated that the molecular approach is effective for identifying Pheretima in NXTC. Therefore, DNA identification may contribute to the quality control and assurance of NXTC.http://link.springer.com/article/10.1186/s13020-019-0264-7PheretimaNaoxintong capsuleDNA identificationCOI gene
spellingShingle Xiaoxiao Zhu
Hoi-Yan Wu
Pang-Chui Shaw
Wei Peng
Weiwei Su
Specific DNA identification of Pheretima in the Naoxintong capsule
Chinese Medicine
Pheretima
Naoxintong capsule
DNA identification
COI gene
title Specific DNA identification of Pheretima in the Naoxintong capsule
title_full Specific DNA identification of Pheretima in the Naoxintong capsule
title_fullStr Specific DNA identification of Pheretima in the Naoxintong capsule
title_full_unstemmed Specific DNA identification of Pheretima in the Naoxintong capsule
title_short Specific DNA identification of Pheretima in the Naoxintong capsule
title_sort specific dna identification of pheretima in the naoxintong capsule
topic Pheretima
Naoxintong capsule
DNA identification
COI gene
url http://link.springer.com/article/10.1186/s13020-019-0264-7
work_keys_str_mv AT xiaoxiaozhu specificdnaidentificationofpheretimainthenaoxintongcapsule
AT hoiyanwu specificdnaidentificationofpheretimainthenaoxintongcapsule
AT pangchuishaw specificdnaidentificationofpheretimainthenaoxintongcapsule
AT weipeng specificdnaidentificationofpheretimainthenaoxintongcapsule
AT weiweisu specificdnaidentificationofpheretimainthenaoxintongcapsule